Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Ligand

June 2, 2020 CD derivatives / Pharma applications

Ligand CEO Issues Letter to Captisol Customers

Yesterday, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that Chief Executive Officer John Higgins issued a letter to Ligand’s Captisol® customers. The

Continue reading

September 27, 2019 Drug delivery / Pharma applications

Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China

SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on

Continue reading

Recent Posts

  • Low melting mixtures: Neoteric green solvents for flavor formulation
  • Cyclodextrins as molecular carriers for biopesticides: a review
  • International Meet on Cell Science and Molecular Biology
  • Cyclodextrins and derivatives in drug delivery: New developments, relevant clinical trials, and advanced products
  • Website registration and abstract submission for 21st International Cyclodextrin Symposium open

Tags

alpha-CD Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (18)
  • Analysis (40)
  • CD as API (234)
  • CD derivatives (290)
  • Cosmetics and toilettry (23)
  • Diagnosis (3)
  • Drug delivery (513)
  • E-ducation (59)
  • Environmental (85)
  • Events (175)
  • Food (145)
  • Gene delivery (12)
  • In Hungarian (4)
  • Life sciences (25)
  • Non-pharma applications (259)
  • Other industrial use (74)
  • Pharma applications (802)
  • Supramolecular systems (30)
  • Uncategorized (62)

Top Posts

  • Australian company pioneering Cavadextrin for regression of atherosclerosis
  • Lanosterol eye drops for cataract treatment
  • Call for Book Chapters in Book "Cyclodextrins in Chemosensing" (Springer Nature)
  • 16th Annual World Cancer Congress
  • Cyclodextrins as molecular carriers for biopesticides: a review
  • The Biological Fate of Pharmaceutical Excipient β-Cyclodextrin: Pharmacokinetics, Tissue Distribution, Excretion, and Metabolism of β-Cyclodextrin in Rats
  • Low melting mixtures: Neoteric green solvents for flavor formulation
  • Website registration and abstract submission for 21st International Cyclodextrin Symposium open
  • Wasabi's bioactive component 6-MSITC formulated with alfa-cyclodextrin improved memory proven in clinical trial.
  • Cyclodextrin-based poly [n]catenanes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 570 other subscribers
 

Loading Comments...